Abstract
Monilethrix is a rare hereditary disorder that affects the hair and is characterized by shaft anomaly. There is no known treatment that successfully cures the condition. In this report we present a case of monilethrix in a 7-year-old girl treated with oral acitretin. A very good clinical and cosmetic result was obtained while treatment was continued. However, clinical symptoms recurred after discontinuation of acitretin therapy.
Similar content being viewed by others
References
Zalka AD, Goldsmith LA, Scott GA, et al. Picture of the month. Arch Pediatr Adolesc Med 1995; 149: 549–50
Landau M, Brenner S, Metzker A. Medical pearl: an easy way to diagnose severe neonatal monilethrix. J Am Acad Dermatol 2002; 46: 111–2
Karaman GC, Sendur N, Basar H, et al. Localized monilethrix with improvement after treatment of iron deficiency anaemia. J Eur Acad Dermatol Venereol 2001; 15: 362–4
Harper J, Orange A, Prose N. Hair disorders. In: Olsen EA, editor. Text book of pediatric dermatology. Vol 2. London: Blackwell Science, 2002: 1463–90
Jury IS, Korges BP, Hamm M. Phenotype and prognosis in monilethrix due to mutations of hair keratins hHb 1 and hHb 6. Br J Dermatol 1999; 141 Suppl. 55: 102–7
Zlotogorski A, Christiano AM. Mapping of monilethrix and papular atrichia [letter]. Dermatology 1995; 190: 89
Smith F. The molecular genetics of keratin disorders. Am J Clin Dermatol 2003; 4: 347–64
Winter H, Rogers MA, Langbein L, et al. Mutations in the hair cortex keratin hHb6 cause the inherited hair disease monilethrix. Nat Genet 1997; 16 (4): 372–4
Thai K, Sinclair RD, Rodney D. Keratosis pilaris and hereditary koilonychia without monilethrix. J Am Acad Dermatol 2001; 45: 627–9
Braun-Falco O, Plewing G, Wolff HH, et al., editors. Diseases of hair. Berlin: Springer, 2000
Gebhardt M, Fischer T, Claussen U, et al. Monilethrix improvement by hormonal influences? Pediatr Dermatol 1999; 16: 297–300
de Berker D, Dawber RP. Monilethrix treated with oral retinoids. Clin Exp Dermatol 1991; 16: 226–8
Tamayo L. Monilethrix treated with the oral retinoid Ro 10-9359 (Tigason). Clin Exp Dermatol 1983; 8 (4): 393–6
Brecher AR, Orlow SJ. Oral retinoid therapy for dermatologic conditions in children and adolescents. J Am Acad Dermatol 2003; 49: 171–82
Hartschuh W. Successful retinoid therapy of Netherton Syndrome. Hautarzt 1989; 40 Suppl. 7: 430–3
Al-Khenaizan S. Papillon-Lefevre syndrome: the response to acitretin. Int J Dermatol 2002; 41 (12): 938–41
Traupe H, Happle R. Etretinate therapy in children with severe keratinization defects. Eur J Pediatr 1985; 143: 166–9
Ruiz-Maldonado R, Tamayo-Sanchez L, Orozco-Covarrubias ML. The use of retinoids in the pediatric patient. Dermatol Clin 1998; 16: 553–69
Prendiville J, Bingham EA, Burrows D. Premature epiphyseal closure a complication of etretinate therapy in children. J Am Acad Dermatol 1986; 15: 1259–62
Lacour M, Mehta-Nikhar M, Atherton DJ, et al. An appraisal of acitretin therapy in children with inherited disorders of keratinization. Br J Dermatol 1996; 134: 1023–9
Acknowledgment
The authors have provided no information on sources of funding or on conflicts of interest directly relevant to the content of this case report.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Karincaoglu, Y., Coskun, B.K., Seyhan, M.E. et al. Monilethrix. Am J Clin Dermatol 6, 407–410 (2005). https://doi.org/10.2165/00128071-200506060-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128071-200506060-00008